Amino.Desk

Thymalin

Updated Nov 17, 2026 · Clinical review: pending

Thymalin is an extract of calf thymus that has been a registered immune drug in Russia since the Soviet era. It is sold abroad for immune support and longevity. The human evidence comes from the group that developed it and has not been independently repeated.

What it is

A preparation of small peptides extracted from the thymus glands of calves. It was approved as a drug in the Soviet Union in 1982 for immune deficiency states. It was developed by Vladimir Khavinson and Vladimir Morozov, and it is the starting point for the family of short peptides sold as bioregulators. Two of those, Thymogen and Vilon, are single peptides identified from this extract.

What the evidence shows

The most-cited study followed 266 elderly people for six to eight years and reported lower mortality in those given thymus and pineal extracts. It was not blinded, it comes from the developers, and it has not been reproduced elsewhere in more than twenty years.

Inside Russia the drug has critics. A vice president of the Russian Society of Evidence-Based Medicine Specialists has said it was approved with very little evidence of effectiveness, and a Russian drug handbook cited by St. Petersburg journalists lists it as having no proven efficacy.

Legal status

Reported dosing

We do not publish a protocol for this compound.

The Russian product has its own label, which we have not been able to check directly. The schedules on English-language sites come from sellers and enthusiast guides.

Safety

Common questions

Is Thymalin FDA-approved?

No. It is registered in Russia only.

Is Thymalin a single peptide?

No. It is a mixture of peptides extracted from calf thymus.

Does Thymalin extend life?

One unblinded study from its developers reported lower mortality in elderly people. Nobody has repeated it.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy